Broncho-pulmonary nosocomial infection (BPNI) has the highest incidence of nosocomial infection in intensive care unit (ICU) and is associated with substantial morbidity and mortality. The objective of this study is to determine the risk factors for BPNI and improve the prevention of this infection.

Patients and methods
====================

Characteristics of all patients admitted in a 30-beds university medical ICU were prospectively collected from 03/93 to 09/99. The diagnosis criteria for nosocomial pneumonia and bronchitis were those published by the CDC. Patients with first BPNI were compared to the others by univariate and multivariate analysis.

Results
=======

We diagnosed 517 first BPNI representing: 12% of the 3681 patients hospitalised in our unit, 11.6 episodes/1000 days of hospitalization and 16 episodes/1000 days of ventilation. Microbiology studies were positives for 455 (88%) BPNI: *Acinetobacter* (28.1%), *P. aeruginosa* (23.1%), *Staphylococcus aureus* (12.6%). The 517 BPNI included 282 (54.5%) pneumonia and 235 (45.5%) bronchitis.

Conclusion
==========

Prevention of BPNI should consider all measures to decrease ICU stay, length of mechanical ventilation and the use of steroids, sedatives, H2-blockers, omeprazole, sucralfate and ATB therapy; especially in patients with renal failure.

  Patient characteristics                   General population   BPNI
  ----------------------------------------- -------------------- ---------
  Age (years)                               58                   62
  Sex ratio (M/F)                           1.84                 2.54
  Mortality (%)                             35.9                 53.5
  Mechanical ventilation (%)                85.1                 97
  ICU stay (days)                           12.2                 32.6
  Length of mechanical ventilation (days)   10.5                 26.5
  SAPS II                                   37.1                 36.5 NS
  Total Omega                               245                  347
  Surgical patients (%)                     15.3                 20.3

Univariate analysis identified the following risk factors (*P* \< 0.05): At admission: Male gender, age \> 60, chronic lung disease antecedent, previous corticosteroid treatment, antibiotics (ATB) in the previous 2 weeks, surgery or trauma \< 24 hours, secondary hospitalization, broncho-pulmonary infection, sedatives use; respiratory, renal or digestive distress. During hospitalization: Mechanical ventilation, total omega score; ATB, omeprazole, ranitidine or sucralfate use.

  Multivariate analysis               Odds ratio   IC (95%)
  ----------------------------------- ------------ ------------
  H2-blockers or omeprazole use       5.53         3.35--9.12
  Sucralfate use                      2.66         2.05--3.46
  Previous corticosteroid treatment   1.93         1.46--2.56
  Renal failure                       1.52         1.10--2.10
  Number of ATB                       1.27         1.12--1.44
  Length of mechanical ventilation    1.06         1.05--1.08
  Stay in ICU                         1.05         1.03--1.06
